SPONSOR
Changhai Hospital
Total Trials
7
Recruiting
7
Phases
EARLY_Phase 1
Conditions studied: Early Esophageal CancerEpiDural HematomaTraumatic Brain InjuryPancreatic CancerDiabetesFamilial Pancreatic CancerPancreatic Cystic NeoplasmChronic PancreatitisHereditary PancreatitisInflammatory Bowel Diseases
Changhai Hospital is a clinical research sponsor with 7 registered studies on ClinicalTrials.gov, of which 7 are actively recruiting participants. Research covers conditions including Early Esophageal Cancer, EpiDural Hematoma, Traumatic Brain Injury, Pancreatic Cancer.
The trial portfolio spans EARLY_Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Changhai Hospital
How many clinical trials has Changhai Hospital sponsored?
ClinicalMetric currently tracks 7 clinical trials sponsored by Changhai Hospital, of which 7 are actively recruiting participants. These trials cover conditions including Early Esophageal Cancer, EpiDural Hematoma, Traumatic Brain Injury. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Changhai Hospital research focus on?
Changhai Hospital clinical trials span Early Esophageal Cancer, EpiDural Hematoma, Traumatic Brain Injury, Pancreatic Cancer, Diabetes, and additional conditions. The research pipeline includes EARLY_Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Changhai Hospital clinical trial?
To participate in a Changhai Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Changhai Hospital trials with current recruitment status updated daily.
Clinical Trials by Changhai Hospital
NCT06515964
Recruiting
China Early Esophageal Cancer Cohort
Early Esophageal Cancer
NCT06292585
Recruiting
Acute EpiDural Hematoma Treated With Middle Meningeal Artery Embolization: a Randomized Trial (AEDH-MT)
EpiDural Hematoma
NCT04743479
Recruiting
Artificial Intelligence-based Early Screening of Pancreatic Cancer and High Risk Tracing (ESPRIT-AI)
Pancreatic Cancer
NCT06512792
Recruiting
Mobile App-Based Remote Management Model for IBD Patient
Inflammatory Bowel Diseases
NCT07202559
Recruiting
Indometacin With or Without Aggressive Intravenous Hydration to Prevent Pancreatitis After Pancreatic Extracorporeal Shock Wave Lithotripsy
Pancreatitis, Chronic
NCT07246096 EARLY_Phase 1
Recruiting
Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases
Autoimmune Diseases
NCT06335693
Recruiting
Adjuvant Hypofractionated Radiotherapy for Prostate Cancer
Prostate Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology